molecular function |
| GO:0005125 | | cytokine activity | | Functions to control the survival, growth, differentiation and effector function of tissues and cells. |
| GO:0004857 | | enzyme inhibitor activity | | Binds to and stops, prevents or reduces the activity of an enzyme. |
| GO:0008083 | | growth factor activity | | The function that stimulates a cell to grow or proliferate. Most growth factors have other actions besides the induction of cell growth or proliferation. |
| GO:0046872 | | metal ion binding | | Interacting selectively and non-covalently with any metal ion. |
| GO:0008191 | | metalloendopeptidase inhibitor activity | | Stops, prevents or reduces the activity of metalloendopeptidases, enzymes that catalyze the hydrolysis of nonterminal peptide bonds in a polypeptide chain and contain a chelated metal ion at their active sites which is essential to their catalytic activity. |
| GO:0030414 | | peptidase inhibitor activity | | Stops, prevents or reduces the activity of a peptidase, any enzyme that catalyzes the hydrolysis peptide bonds. |
| GO:0002020 | | protease binding | | Interacting selectively and non-covalently with any protease or peptidase. |
| GO:0005515 | | protein binding | | Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules). |
biological process |
| GO:0007568 | | aging | | A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700). |
| GO:0051216 | | cartilage development | | The process whose specific outcome is the progression of a cartilage element over time, from its formation to the mature structure. Cartilage elements are skeletal elements that consist of connective tissue dominated by extracellular matrix containing collagen type II and large amounts of proteoglycan, particularly chondroitin sulfate. |
| GO:0001775 | | cell activation | | A change in the morphology or behavior of a cell resulting from exposure to an activating factor such as a cellular or soluble ligand. |
| GO:0022617 | | extracellular matrix disassembly | | A process that results in the breakdown of the extracellular matrix. |
| GO:0043066 | | negative regulation of apoptotic process | | Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process. |
| GO:0043086 | | negative regulation of catalytic activity | | Any process that stops or reduces the activity of an enzyme. |
| GO:0010951 | | negative regulation of endopeptidase activity | | Any process that decreases the frequency, rate or extent of endopeptidase activity, the endohydrolysis of peptide bonds within proteins. |
| GO:0051045 | | negative regulation of membrane protein ectodomain proteolysis | | Any process that stops, prevents, or reduces the frequency, rate or extent of membrane protein ectodomain proteolysis. |
| GO:0010466 | | negative regulation of peptidase activity | | Any process that stops or reduces the rate of peptidase activity, the hydrolysis of peptide bonds within proteins. |
| GO:1901164 | | negative regulation of trophoblast cell migration | | Any process that stops, prevents or reduces the frequency, rate or extent of trophoblast cell migration. |
| GO:0002576 | | platelet degranulation | | The regulated exocytosis of secretory granules containing preformed mediators such as histamine and serotonin by a platelet. |
| GO:0008284 | | positive regulation of cell proliferation | | Any process that activates or increases the rate or extent of cell proliferation. |
| GO:2001044 | | regulation of integrin-mediated signaling pathway | | Any process that modulates the frequency, rate or extent of integrin-mediated signaling pathway. |
| GO:0034097 | | response to cytokine | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus. |
| GO:0009725 | | response to hormone | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hormone stimulus. |
| GO:0010033 | | response to organic substance | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic substance stimulus. |
| GO:0043434 | | response to peptide hormone | | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptide hormone stimulus. A peptide hormone is any of a class of peptides that are secreted into the blood stream and have endocrine functions in living animals. |
| GO:0042060 | | wound healing | | The series of events that restore integrity to a damaged tissue, following an injury. |
cellular component |
| GO:0005604 | | basement membrane | | A thin layer of dense material found in various animal tissues interposed between the cells and the adjacent connective tissue. It consists of the basal lamina plus an associated layer of reticulin fibers. |
| GO:0070062 | | extracellular exosome | | A vesicle that is released into the extracellular region by fusion of the limiting endosomal membrane of a multivesicular body with the plasma membrane. Extracellular exosomes, also simply called exosomes, have a diameter of about 40-100 nm. |
| GO:0031012 | | extracellular matrix | | A structure lying external to one or more cells, which provides structural support for cells or tissues. |
| GO:0005576 | | extracellular region | | The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite. |
| GO:0005615 | | extracellular space | | That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid. |
| GO:0031093 | | platelet alpha granule lumen | | The volume enclosed by the membrane of the platelet alpha granule. |
| GO:0005578 | | proteinaceous extracellular matrix | | A layer consisting mainly of proteins (especially collagen) and glycosaminoglycans (mostly as proteoglycans) that forms a sheet underlying or overlying cells such as endothelial and epithelial cells. The proteins are secreted by cells in the vicinity. An example of this component is found in Mus musculus. |